Can volume indices of total, free, and complex prostate-specific antigen enhance the prediction of the pathologic stage of clinical T1C prostate cancer?

被引：0
|
作者：
Naya, Y
Fritsche, HA
Stamey, TA
Cheli, CD
Partin, AW
Sokoll, LL
Chan, DW
Brawer, MK
Taneja, SS
Lepor, H
Bartsch, G
Childs, S
Babaian, RJ
机构：
来源：
JOURNAL OF UROLOGY | 2003年 / 169卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
1137
引用
收藏
页码：293 / 293
页数：1
相关论文
共 50 条
  • [41] Clinical evaluation of free PSA total PSA (prostate-specific antigen) ratio in the diagnosis of prostate cancer
    Filella, X
    Alcover, J
    Molina, R
    Rodriguez, A
    Carretero, P
    Ballesta, AM
    EUROPEAN JOURNAL OF CANCER, 1997, 33 (08) : 1226 - 1229
  • [42] Prostate cancer risk prediction based on clinical factors and prostate-specific antigen
    Taewon Hwang
    Hyungseok Oh
    Jung Ah Lee
    Eo Jin Kim
    BMC Urology, 23
  • [43] Prostate cancer risk prediction based on clinical factors and prostate-specific antigen
    Hwang, Taewon
    Oh, Hyungseok
    Lee, Jung Ah
    Kim, Eo Jin
    BMC UROLOGY, 2023, 23 (01)
  • [44] Clinical characterization of free and total prostate specific antigen in prostate cancer
    Lee, JW
    Lim, WS
    Kwon, OH
    Chung, BH
    Hong, SJ
    CLINICAL CHEMISTRY, 1996, 42 (06) : 706 - 706
  • [45] Analysis of percent free prostate-specific antigen (PSA) for prostate cancer detection: Influence of total PSA, prostate volume, and age
    Partin, AW
    Catalona, WJ
    Southwick, PC
    Subong, ENP
    Gasior, GH
    Chan, DW
    UROLOGY, 1996, 48 (6A) : 55 - 61
  • [46] Free Prostate-specific Antigen Is a Better Tool Than Total Prostate-specific Antigen at Predicting Prostate Volume in Patients With Lower Urinary Tract Symptoms
    Kayikci, Ali
    Cam, Kamil
    Kacagan, Coskun
    Tekin, Ali
    Ankarali, Handan
    UROLOGY, 2012, 80 (05) : 1088 - 1092
  • [47] Value of percent free prostate-specific antigen for the prediction of pathological stage in men with clinically localized prostate cancer
    Morote, J
    Trilla, E
    Esquena, S
    Serrallach, F
    Abascal, JM
    H'Mammed, YI
    de Torres, IM
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2002, 17 (04): : 239 - 243
  • [48] MANAGEMENT OF STAGE T1C PROSTATE-CANCER
    GIBBONS, RP
    CANCER, 1995, 75 (07) : 1900 - 1902
  • [49] Adding free to total prostate-specific antigen levels in trials of prostate cancer screening
    Wald, NJ
    Watt, HC
    George, L
    Knekt, P
    Helzlsouer, KJ
    Tuomilehto, J
    BRITISH JOURNAL OF CANCER, 2000, 82 (03) : 731 - 736
  • [50] Predicting prostate specific antigen failure after radical retropubic prostatectomy for T1c prostate cancer
    Ou, YC
    Chen, JT
    Yang, CR
    Cheng, CL
    Ho, HC
    Ko, JL
    Hsieh, YS
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2002, 32 (12) : 536 - 542
12345